Neurostimulation devices are medical devices that deliver electrical signals to the brain, peripheral nervous system, and/or spinal cord. They are used to treat a variety of neurological disorders, such as chronic pain, epilepsy, Parkinson’s disease, and depression. Neurostimulation devices can be implanted or non-invasive. Implantable neurostimulation devices include deep brain stimulation (DBS), sacral nerve stimulation (SNS), and spinal cord stimulation (SCS). Non-invasive devices include transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).
Neurostimulation devices can be used to modulate various neural activities, such as controlling pain, restoring movement in paralyzed muscles, and treating depression. They can also be used to assess the state of the nervous system, such as in brain-computer interfaces (BCIs).
The global neurostimulation device market is projected to reach USD 14.68 billion by 2027, growing at a CAGR of 9.5% during the forecast period. The increasing prevalence of neurological disorders and the growing demand for minimally invasive treatments are driving the growth of the market. The increasing investments in research and development (R&D) activities and the rising adoption of advanced technologies are some of the factors driving the growth of the market.
The global Neurostimulation Devices market was valued at US$ 6640 million in 2022 and is anticipated to reach US$ 14170 million by 2029, witnessing a CAGR of 11.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Neurostimulation Devices Market available at: https://www.themarketreports.com/report/global-neurostimulation-devices-market-research-report
The global Neurostimulation Devices market was valued at US$ 6640 million in 2022 and is anticipated to reach US$ 14170 million by 2029, witnessing a CAGR of 11.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
The major global companies of Neurostimulation Devices include Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical etc. In 2021, the world’s top three vendors accounted for approximately % of the revenue.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1408780
Release by:
Shirish Gupta
Marketing Manager
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com